Table S2.
Characteristics of risk prediction models in cirrhosis, CHC patients and general population
| Factors | Risk predictors | Prediction risk score in cirrhosis patients (category) | Prediction risk score in CHC patients (category) | ||||||||
| ADRESS | AFP-Based Algorithm (no score) | Chang | Chang (SVR) | Michikawa | |||||||
| No. of model | 1 | 1 | 1 | 1 | 1 | ||||||
| CHC, chronic hepatitis C; HCV, hepatitis C virus; CLD, chronic liver disease; BMI, body mass index; DM, diabetes mellitus; Anti-HCV, anti-hepatitis C virus antibody; HBsAg, hepatitis B surface antigen; SVR, sustained virological response; CTP, Child-Turcotte-Pugh; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; AST, serum aspartate transaminase; MET, metabolic equivalent. | |||||||||||
| Host factors | Age | years×0.0532 entered as continuous variable | √ | 0 (<60 years) | 0 (<60 years) | 0 (40-49 years) | |||||
| 1 (≥60 years) | 5 (≥60 years) | 2 (50-59 years) | |||||||||
| 3 (60-69 years) | |||||||||||
| Gender | 0 (female) | 0 (female) | 0 (female) | ||||||||
| 0.5114 (male) | 1 (male) | 2 (male) | |||||||||
| Race | 0 (non-Hispanic white) | ||||||||||
| 0.2058 (nonwhite or Hispanic) | |||||||||||
| BMI | 0 (<25 kg/m2) | ||||||||||
| 1 (≥25 kg/m2) | |||||||||||
| DM | 0 (no) | ||||||||||
| 0.2135 (yes) | |||||||||||
| Environmental factors | Alcohol | 0 (<450 g/week ethanol or past) | |||||||||
| 1 (never) | |||||||||||
| 2 (≥450 g/week ethanol) | |||||||||||
| Virological factors | HCV genotype | 0 (non G1b) | −1 (ribonucleic acid-negative) | ||||||||
| 1 (G1b) | 0 (G2) | ||||||||||
| 2 (G1) | |||||||||||
| SVR | 0 (yes) | ||||||||||
| 2 (no) | |||||||||||
| Liver-related seromarkers | Cirrhosis | 0 (autoimmune) | 0 (fibrosis stage: 0-2) | 0 (fibrosis stage: 0-2) | |||||||
| 0.3509 (alcohol/metabolic) | 2 (fibrosis stage: 3-4) | 6 (fibrosis stage: 3-4) | |||||||||
| 1.246 (viral) | |||||||||||
| Severity of CTP | CTP score×0.0532 entered as continuous variable | ||||||||||
| ALT | √ | 0 (<30 IU/L) | |||||||||
| 3 (30-69 IU/L) | |||||||||||
| 5 (≥70 IU/L) | |||||||||||
| AFP | √ | 0 (<20 ng/mL) | 0 (<20 ng/mL) | ||||||||
| 1 (≥20 ng/mL) | 4 (≥20 ng/mL) | ||||||||||
| Platelet | √ | 0(≥150×109/L) | 0(≥150×109/L) | ||||||||
| 1(<150×109/L) | 4(<150×109/L) | ||||||||||
| Sum | − | − | 0-9 | 0-19 | −1-15 | ||||||
| Factors | Risk predictors | Prediction risk score in general population (category) | |||||||||
| Michikawa | Wen | ||||||||||
| No. of model | 1 | 9 | |||||||||
| Host factors | Age | 0 (40-49 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) |
| 2 (50-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | 2 (40-59 years) | ||
| 3 (60-69 years) | 6 (≥60 years) | 6 (≥60 years) | 6 (≥60 years) | 6 (≥60 years) | 6 (≥60years) | 6 (≥60 years) | 6 (≥60 years) | 6 (≥60 years) | 6 (≥60 years) | ||
| Gender | 0 (female) | 0 (female) | 0 (female) | 0 (female) | 0 (female) | 0 (female) | 0 (female) | 0 (female) | |||
| 2 (male) | 2 (male) | 2 (male) | 1 (male) | 1 (male) | 1 (male) | 1 (male) | 1 (male) | ||||
| BMI | 0 (<25 kg/m2) | ||||||||||
| 1 (≥25 kg/m2) | |||||||||||
| Physical activity | 0 (<3.75 MET-h) | 0 (<7.5 MET-h) | 0 (<7.5 MET-h) | 0 (<7.5 MET-h) | |||||||
| −1 (≥3.75 MET-h) | −1 (≥7.5 MET-h) | −1 (≥7.5 MET-h) | −1 (≥7.5 MET-h) | ||||||||
| DM | 0 (no) | 0 (no) | 0 (no) | 0 (no) | 0 (no) | 0 (no) | 0 (no) | 0 (no) | |||
| 1 (yes) | 2 (yes) | 1 (yes) | 1 (yes) | 1 (yes) | 1 (yes) | 1 (yes) | 1 (yes) | ||||
| Environmental factors | Smoking | 0 (<1 pack-years) | 0 (<1 pack-years) | 0 (<10 pack-years) | 0 (<10 pack-years) | 0 (<10 pack-years) | 0 (<10 pack-years) | 0 (<10 pack-years) | |||
| 1 (≥1 pack-years) | 1 (≥1 pack-years) | 1 (≥10 pack-years) | 1 (≥10 pack-years) | 1 (≥10 pack-years) | 1 (≥10 pack-years) | 1 (≥10 pack-years) | |||||
| Alcohol | 0 (<450 g/week ethanol) | 0 (none or occasional) | 0 (none or occasional) | 0 (none or occasional) | 0 (none or occasional) | 0 (none or occasional) | 0 (none or occasional) | 0 (none or occasional) | |||
| 1 (never or past) | 1 (regular) | 1 (regular) | 1 (regular) | 1 (regular) | 1 (regular) | 1 (regular) | 1 (regular) | ||||
| 2 (≥450 g/week ethanol)) | |||||||||||
| Coffee | 0 (almost never to <1 cup/d) | ||||||||||
| −1 (≥1 cup/d) | |||||||||||
| Virological factors | Anti-HCV | 0 (negative) | 0 (negative) | ||||||||
| 6 (positive) | 5 (positive) | ||||||||||
| HBsAg | 0 (negative) | 0 (negative) | 0 (negative) | 0 (negative) | |||||||
| 4 (positive) | 4 (positive) | 4 (positive) | 6 (positive) | ||||||||
| Liver-related seromarkers | ALT | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | |||
| 2 (≥25 IU/L) | 1 (≥25 IU/L) | 1 (≥25 IU/L) | 3 (≥25 IU/L) | 1 (≥25 IU/L) | 2 (≥25 IU/L) | 2 (≥25 IU/L) | |||||
| AFP | 0 (<2.5 ng/mL) | 0 (<2.5 ng/mL) | 0 (<2.5 ng/mL) | ||||||||
| 1 (2.5-4.9 ng/mL) | 2 (2.5-4.9 ng/mL) | 2 (2.5-4.9 ng/mL) | |||||||||
| 4 (5.0-9.9 ng/mL) | 5 (5.0-9.9 ng/mL) | 5 (5.0-9.9 ng/mL) | |||||||||
| 8 (≥10.0 ng/mL) | 9 (≥10.0 ng/mL) | 9 (≥10.0 ng/mL) | |||||||||
| AST | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | ||||
| 5 (25-39 IU/L) | 4 (25-39 IU/L) | 4 (25-39 IU/L) | 4 (25-39 IU/L) | 5 (25-39 IU/L) | 4 (25-39 IU/L) | 4 (25-39 IU/L) | |||||
| 9 (40-59 IU/L) | 9 (40-59 IU/L) | 7 (≥40 IU/L) | 8 (40-59 IU/L) | 8 (40-59 IU/L) | 6 (40-59 IU/L) | 6 (40-59 IU/L) | |||||
| 13 (≥60 IU/L) | 12 (≥60 IU/L) | 11 (≥60 IU/L) | 11 (≥60 IU/L) | 8 (≥60 IU/L) | 7 (≥60 IU/L) | ||||||
| Sum | −1-19 | −1-12 | 0-23 | −1-23 | −1-30 | −1-10 | 0-21 | 0-21 | 0-32 | 0-39 | |
| Factors | Risk predictors | Prediction risk score in general population (category) | |||||||||
| Hung | |||||||||||
| No. of model | 4 | ||||||||||
| Host factors | Age | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | 0 (20-39 years) | ||||||
| 3 (40-49 years) | 3 (40-49 years) | 3 (40-49 years) | 3 (40-49 years) | ||||||||
| 5 (50-59 years) | 5 (50-59 years) | 5 (50-59 years) | 5 (50-59 years) | ||||||||
| 7 (≥60 years) | 7 (≥60 years) | 7 (≥60 years) | 7 (≥60 years) | ||||||||
| Gender | 0 (female) | 0 (female) | 0 (female) | 0 (female) | |||||||
| 3 (male) | 3 (male) | 3 (male) | 3 (male) | ||||||||
| First-degree family history of HCC | 0 (no) | 0 (no) | 0 (no) | ||||||||
| 2 (yes) | 2 (yes) | 2 (yes) | |||||||||
| Environmental factors | Smoking | 0 (<18 pack-years) | 0 (<18 pack-years) | 0 (<18 pack-years) | |||||||
| 1 (≥18 pack-years) | 1 (≥18 pack-years) | 1 (≥18 pack-years) | |||||||||
| Virological factors | HBsAg or Anti-HCV | 0 (negative) | |||||||||
| 9 (positive) | |||||||||||
| HBsAg | 0 (negative) | ||||||||||
| 7 (positive) | |||||||||||
| Liver-related seromarkers | ALT | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | 0 (<25 IU/L) | ||||||
| 3 (≥25 IU/L) | 3 (≥25 IU/L) | 3 (≥25 IU/L) | 3 (≥25 IU/L) | ||||||||
| Previous CLD | 0 (no) | 0 (no) | 0 (no) | ||||||||
| 3 (yes) | 3 (yes) | 3 (yes) | |||||||||
| Sum | 0-13 | 0-19 | 0-26 | 0-28 | |||||||